Van Hemelryck S, Van Landuyt E, Hufkens V, Vanveggel S, et al. Assessment of swallowability and acceptability of scored darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) fixed-dose combination (FDC) tablets in HIV-1-infected children aged >/=6 to <12 years, using matching placebo tablets: A ran Antivir Ther 2024;29:13596535241248282.
PMID: 38725258